Overview

Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of escalating multiple oral doses of varenicline AMT 8 controlled release formulation for 14 days in adult smokers.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Varenicline